Hodge et al. reported that hypermethylation of the p53 promoter region, which was epigenetically modified by DNMT1, resulted in reduced levels of p53 expression in an IL-6-responsive multiple myeloma cell line33. The gene discussed is TP53; the disease is plasma cell myeloma.